Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23372680 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure
Condition: Mild Traumatic Brain Injury
Interventions: Drug: N-acetyl-cysteine (NAC);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.